Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Withdrawn 1Recruiting 1

Sponsor Class

OTHER 13NIH 2NETWORK 2UNKNOWN 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Squamous Cell Carcinoma of Head and Neck 12Prostatic Neoplasms 9Head and Neck Neoplasms 9Brain Neoplasms 6Uterine Cervical Neoplasms 4Tongue Neoplasms 4Central Nervous System Neoplasms 4Papillomavirus Infections 3Radiation Injuries 2Precancerous Conditions 2Oropharyngeal Neoplasms 2Oligodendroglioma 2Neurotoxicity Syndromes 2Mouth Neoplasms 2Laryngeal Neoplasms 2Hypopharyngeal Neoplasms 2Endometrial Neoplasms 2Carcinoma 2Astrocytoma 2Anus Neoplasms 2Anal Canal Carcinoma 2Vulvar Neoplasms 1Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 1Salivary Gland Neoplasms 1Postoperative Complications 1Pancreatic Neoplasms 1Optic Nerve Glioma 1Obesity 1Neuroblastoma 1Neoplasms 1

Interventions

Platinum 4Cisplatin 4Carboplatin 31,2-diaminocyclohexaneplatinum II citrate 3regorafenib 2pegfilgrastim 2Radiotherapy, Intensity-Modulated 2Paclitaxel 2Magnetic Resonance Spectroscopy 2Doxorubicin 2Docetaxel 2Bevacizumab 2trifluridine tipiracil drug combination 1pembrolizumab 1merphos 1dehydroftorafur 1X-Rays 1Vinblastine 1Trifluridine 1Taxes 1Specimen Handling 1Radiotherapy, Image-Guided 1Radiotherapy 1Radiation 1Nivolumab 1Nephroureterectomy 1N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide 1Methotrexate 1Irinotecan 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Carcinoma × Radiotherapy, Intensity-Modulated × Clear all
NCT02734537 2026-05-15

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Eastern Cooperative Oncology Group

Phase 2 Recruiting
189 enrolled
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms

NCT06084845 2024-07-25

Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carboplatin for Patients With Head and Neck Cancer

Eastern Cooperative Oncology Group

Phase 2 Withdrawn
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡